-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
-
Bullseye Biosciences
By leveraging competition and evolution, Bullseye aims to transform therapeutics discovery and expedite the development of life-saving medicines.
-
Concerto Biosciences
Discovering microbial ensembles for health via a patented screening platform.
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
-
GC Therapeutics
Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
-
InGel Therapeutics
Regenerative cell-therapy biotech aiming to treat people affected by blindness.
-
JustFix
Building free tools for tenants to exercise their rights to a livable home.
-
Kinnos
Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
-
MabLab
Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
-
ReThink
An app that detects online hate and gives users a second chance to reconsider the decision to post or send offensive messages.
-
SchoolYourself
Reinventing online math education in the style of 1-on-1 learning.
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.
-
Vaxess Technologies
Developing a novel transdermal patch technology to transform home delivery of therapies and vaccines
Take On the Challenge
Students: Apply for the PIC by Dec. 05.